|
|
Life Science Media Library
|
Understanding EMT: Mechanisms and Metastasis to MET DVD
February 20, 2012 |
Escherichia coli has proven its worth as a protein expression platform. Currently, E.coli is not viewed so much as an ‘alternative’ platform, but as a viable choice for achieving high-level expression of human genes and proteins at a reasonable cost.
|
CTCs from Bench to Bed DVD
February 20, 2012 |
Escherichia coli has proven its worth as a protein expression platform. Currently, E.coli is not viewed so much as an ‘alternative’ platform, but as a viable choice for achieving high-level expression of human genes and proteins at a reasonable cost.
|
Latest Advances in Molecular Pathology DVD
February 20, 2012 |
Escherichia coli has proven its worth as a protein expression platform. Currently, E.coli is not viewed so much as an ‘alternative’ platform, but as a viable choice for achieving high-level expression of human genes and proteins at a reasonable cost.
|
|
|
|
Publications, Reports, & Whitepapers
|
Next Generation Mass Spectrometry
Author: K. John Morrow, Jr., PhD
Advances in biomedical instrumentation are enabling a new perspective that could not have been achieved even a decade ago. Mass spectrometry is the most significant and far reaching of these developments, allowing the generation of data in the medical sciences that brings new insights into critical questions.
|
Next Generation Sequencing Generates Momentum
Next Generation Sequencing Generates Momentum: Markets Respond to Technology and Innovation Advances, an Insight Pharma Report, focuses on current and innovative NGS technologies, services and markets.
|
Commercializing Biomarkers in Therapeutic and Diagnostic Applications
Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report, an Insight Pharma Report, focuses on issues that must be addressed to utilize this growing knowledge about biomarkers and successfully commercialize them in therapeutic and diagnostic applications.
|
|
|
|
|